News
-
-
PRESS RELEASE
Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care
Bone Health Technologies (BHT) closes oversubscribed $5 million financing round with new investors, including Terumo Medical, to advance Osteoboost wearable vibration device for postmenopausal women's bone health -
PRESS RELEASE
Bone Health Technologies Announces FDA Clearance of OsteoboostTM, the First Prescription Medical Device to Treat Low Bone Density
Bone Health Technologies announces FDA clearance for Osteoboost, a non-pharmacological prescription treatment for postmenopausal women with osteopenia. Osteoboost is a wearable device that delivers targeted vibration to the lumbar spine and hips to reduce bone strength and density decline. This breakthrough technology is safe, medication-free, and has shown efficacy in reducing bone strength loss. The clearance represents a significant advancement in the treatment of low bone density, addressing an underserved need in women's health.
-
Buildout, Inc. Unveils Game-Changing Technology Stack including an AI-Enabled Mobile App
-
Heal and Find Hope After a Friendship Breakup in When Best Friends Aren't Forever by Kristen Reed, Out Now
-
Viking Capital Announces Closing of Latest 268 Acquisition in Atlanta
-
Aflac: 6 Common Myths About Supplemental Insurance
-
Gabriel Resources Ltd. Initial Closing of Private Placement
-
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
-
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
-
M&G Credit Income Investment Trust plc: Net Asset Value(s)
-
Funding Circle Plc: POS-Transaction in Own Shares
-
Explore Copenhagen's Culinary Gem: Khun Juk Oriental, Winner of the 2023 Thai Select Signature Award and Esteemed Taittinger Ambassador
-
VOGO : French National Handball League chooses VOGO to referee the French men’s championship (“Liqui Moly Starligue”).
-
ENGIE Q1 2024 Financial Information
-
Covivio Hotels successfully priced a €500 million 9-year Green Bond
-
Covivio Hotels successfully priced a €500 million 9-year Green Bond
-
AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2024